• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质金属蛋白酶-1组织抑制剂在人乳腺癌中的表达

Expression of tissue inhibitor of matrix metalloproteinase-1 in human breast carcinoma.

作者信息

Inoue H, Mimori K, Shiraishi T, Kataoka A, Sadanaga N, Ueo H, Barnard G F, Mori M

机构信息

Department of Surgery, Medical Institute of Bioregulation, Kyushu University, Beppu, Japan.

出版信息

Oncol Rep. 2000 Jul-Aug;7(4):871-4. doi: 10.3892/or.7.4.871.

DOI:10.3892/or.7.4.871
PMID:10854560
Abstract

Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an inhibitor of matrix metalloproteinase (MMP) in human carcinomas. TIMP-1 is thus considered to inhibit carcinoma invasion and metastasis. On the other hand, recent reports have disclosed that TIMP-1 also possesses a growth-promoting function. The clinical significance of TIMP-1 expression has not been fully determined in breast carcinoma. We thus examined the expression of TIMP-1 mRNA in tumor tissues of 100 breast carcinoma cases by a reverse transcriptase-polymerase chain reaction assay. The expression of TIMP-1 mRNA in each case was evaluated semi-quantitatively with adjustment for the TIMP-1 expression in a control breast carcinoma cell line, MCF7. There was a significant inverse correlation between the TIMP-1 expression and lymph node metastasis (p<0.05). A multivariate analysis disclosed that TIMP-1 expression status was an independent determinant factor for lymph node metastasis. In addition, the tumors with positive estrogen or progesterone receptors showed a higher TIMP-1 mRNA expression than those without the receptors, but this did not reach statistical significance. The findings suggest that the breast tumors with high TIMP-1 expression might show less malignant potential than those with low TIMP-1 expression.

摘要

金属蛋白酶组织抑制剂-1(TIMP-1)是人类癌症中基质金属蛋白酶(MMP)的一种抑制剂。因此,TIMP-1被认为可抑制癌症的侵袭和转移。另一方面,最近的报道显示TIMP-1还具有促进生长的功能。TIMP-1表达在乳腺癌中的临床意义尚未完全明确。因此,我们通过逆转录聚合酶链反应分析检测了100例乳腺癌病例肿瘤组织中TIMP-1 mRNA的表达。根据对照乳腺癌细胞系MCF7中的TIMP-1表达情况,对每个病例中TIMP-1 mRNA的表达进行半定量评估。TIMP-1表达与淋巴结转移之间存在显著的负相关(p<0.05)。多因素分析显示,TIMP-1表达状态是淋巴结转移的一个独立决定因素。此外,雌激素或孕激素受体阳性的肿瘤比无受体的肿瘤显示出更高的TIMP-1 mRNA表达,但这未达到统计学意义。这些发现表明,TIMP-1高表达的乳腺肿瘤可能比TIMP-1低表达的肿瘤具有更低的恶性潜能。

相似文献

1
Expression of tissue inhibitor of matrix metalloproteinase-1 in human breast carcinoma.基质金属蛋白酶-1组织抑制剂在人乳腺癌中的表达
Oncol Rep. 2000 Jul-Aug;7(4):871-4. doi: 10.3892/or.7.4.871.
2
Prognostic impact of tissue inhibitor of matrix metalloproteinase-1 in esophageal carcinoma.基质金属蛋白酶-1组织抑制剂在食管癌中的预后影响
Int J Cancer. 2000 Nov 15;88(4):575-8. doi: 10.1002/1097-0215(20001115)88:4<575::aid-ijc9>3.0.co;2-c.
3
High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases.原发性乳腺癌中金属蛋白酶组织抑制剂(TIMP - 1和TIMP - 2)的信使核糖核酸高水平与远处转移的发生相关。
Clin Cancer Res. 1997 Sep;3(9):1623-8.
4
Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer.基质金属蛋白酶-9(MMP-9)和金属蛋白酶组织抑制因子-1(TIMP-1)在乳腺癌血清及组织中的表达及其预后意义
Int J Cancer. 2008 May 1;122(9):2050-6. doi: 10.1002/ijc.23337.
5
Expression of tissue levels of matrix metalloproteinases and their inhibitors in breast cancer.乳腺癌组织中基质金属蛋白酶及其抑制剂的表达。
Breast. 2013 Jun;22(3):330-4. doi: 10.1016/j.breast.2012.08.002. Epub 2012 Sep 18.
6
Clinical significance of MT1-MMP mRNA expression in breast cancer.MT1-MMP mRNA表达在乳腺癌中的临床意义
Oncol Rep. 2001 Mar-Apr;8(2):401-3. doi: 10.3892/or.8.2.401.
7
TIMP-3 mRNA expression levels positively correlates with levels of miR-21 in in situ BC and negatively in PR positive invasive BC.在原位乳腺癌中,TIMP - 3 mRNA表达水平与miR - 21水平呈正相关,而在孕激素受体(PR)阳性的浸润性乳腺癌中呈负相关。
Pathol Res Pract. 2017 Oct;213(10):1264-1270. doi: 10.1016/j.prp.2017.08.012. Epub 2017 Sep 6.
8
[Expression and clinical significance of MMP-2, MMP-9,TIMP-1, and TIMP-2 in breast carcinoma].基质金属蛋白酶-2、基质金属蛋白酶-9、金属蛋白酶组织抑制因子-1及金属蛋白酶组织抑制因子-2在乳腺癌中的表达及临床意义
Ai Zheng. 2003 Sep;22(9):968-73.
9
Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma.基质金属蛋白酶-9与金属蛋白酶组织抑制剂-1的表达失衡在人胃癌侵袭和转移中的作用
World J Gastroenterol. 2003 May;9(5):899-904. doi: 10.3748/wjg.v9.i5.899.
10
[Relationship between the expression of matrix metalloproteinase-13 protein and other biomarkers, prognosis in invasive breast cancer].[基质金属蛋白酶-13蛋白表达与其他生物标志物、浸润性乳腺癌预后的关系]
Zhonghua Bing Li Xue Za Zhi. 2008 Jul;37(7):471-6.

引用本文的文献

1
Proteomics analysis of serum from thymoma patients.胸腺瘤患者血清的蛋白质组学分析。
Sci Rep. 2023 Mar 29;13(1):5117. doi: 10.1038/s41598-023-32339-4.
2
Identification of alternatively spliced TIMP-1 mRNA in cancer cell lines and colon cancer tissue.在癌细胞系和结肠癌组织中鉴定选择性剪接的TIMP-1 mRNA。
Mol Oncol. 2007 Sep;1(2):205-15. doi: 10.1016/j.molonc.2007.05.002. Epub 2007 May 21.